“In this way, we solved one of the key problems of medical care”

“The greatest individual problem in medical care is that people do not take their medication according to their doctors’ instructions. The World Health Organisation states that up to 50 percent (i.e. every second dose) of medication is taken incorrectly. We worked with Protacon in designing the Evondos® medication dosage service, with which the number of errors has been radically reduced. We have reached a correct dosage level of 99.5 percent.

So far, more than 30,000 dosages for more than 150 patients have been administered by the system. Thus, Protacon helped us solve one of the major problems of medical care: medical adherence. We were also praised for our system in an EU-wide eHealth competition, which sought the best innovations to improve the health care sector. While the Evondos® service includes advanced robotics, the most important links are the people involved in the distribution of medication.

During the development stage, we spent several days in the home health care field to collect user experiences. The Evondos® service utilises the automated dosage distribution system used in pharmacies. The Evondos® medicine dispenser tells the user, verbally, by visual or auditory signals or, if necessary, via a phone call, when to take their medication, automatically dosed in pouches. Customers have praised the ease-of-use of the product, as well as its capacity to facilitate everyday life. Families feel safer and patients feel better, in concrete terms.

The service system also creates remarkable cost savings. In the best case, patient visits can be reduced by 90 percent. A direct cost saving varies between EUR 500 and 3,000 per patient in a month. In municipalities with approximately 50,000 inhabitants, the saving could exceed one million euros annually.

We chose Protacon as our partner, as they had the experience in and long-term proof of carrying out demanding development projects in the health care sector. The Evondos® system is placed on the market as a medical device, which are governed by much stricter laws than other systems. This has required a systematic approach from Protacon and the entire team, as well as good documentation, traceability, and close adherence to industry standards and other regulations. The Protacon team has proved to be a highly professional and pleasant partner.

The system has already raised a lot of interest at the international level. The first international deal was closed with two Norwegian municipalities.”

We chose Protacon as our partner, as they had the experience in and long-term proof of carrying out demanding development projects in the health care sector.

Jyrki Niinistö, Managing Director,
Evondos Ltd.